AzTrials
AzTrials

Diabetes (Insulin-requiring, Type 1 or Type 2)NCT07141940

Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients

A study testing Indonesian-language application-based auditory guided imagery therapy and Psychoeducation in people with Diabetes (Insulin-requiring, Type 1 or Type 2) and Insomnia Type; Sleep Disorder, run by Dr Cipto Mangunkusumo General Hospital at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if guided imagery therapy using mobile application in Indonesian language can improve sleep quality and lower fasting blood glucose levels in diabetics patients who have problems with their sleep. Read more about this study

Who is it for?
Ages 18 to 60 years
What is being tested?
Indonesian-language application-based auditory guided imagery therapy and Psychoeducation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteIndonesia
Study dates
6 May 2025to 19 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients at Endocrinology or Psychosomatic Clinic, Cipto Mangunkusumo Hospital
  • Already diagnosed with Diabetes Mellitus
  • HbA1c less than 12%
  • Insomnia Severity Index more than 8
  • Lives in Jakarta, Bogor, Depok, Tangerang, or Bekasi
  • Able to understand the Indonesian language well

Who cannot join

  • History of amputation or routine hemodialysis
  • No device available to connect with the application
  • Inability to independently access or use the application
  • Inability to perform self-monitoring of blood glucose at home
  • Hearing impairment
  • Cognitive impairment or intellectual limitations

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Cipto Mangunkusumo Hospital

    Jakarta Pusat, Jakarta Special Capital Region, 10430

Other trials in Indonesia

About this study

Official title: The Role of Indonesian-Language Application-Based Auditory Guided Imagery Therapy on The Reduction of Insomnia Severity Index and Fasting Blood Glucose Levels in Diabetic Patients With Insomnia

The goal of this clinical trial is to learn if guided imagery therapy using mobile application in Indonesian language can improve sleep quality and lower fasting blood glucose levels in diabetics patients who have problems with their sleep.

The main questions it aims to answer are:

Read more
  • Can the app-based guided imagery therapy help improve sleep quality in diabetic patients who have trouble sleeping?
  • Can the app-based guided imagery therapy help lowering fasting blood glucose in diabetic patients who have trouble sleeping? Researchers will compare app-based guided imagery therapy to education about how to sleep well, to see if the app works to improve sleep quality and lower blood glucose.

Participants will:

  • Receive education about how to sleep well
  • Use the app 3 times a week for 4 weeks (only for group who receive the app)
  • Visit the clinic after 4 weeks for tests
Being tested
Indonesian-language application-based auditory guided imagery therapy, Psychoeducation
Keywords
guided imagery, relaxation therapy, psycoeducation, insomnia, sleep disorders, fasting blood glucose, diabetes mellitus, Indonesian-language, application-based
Medical subject headings
Diabetes Mellitus, Sleep Wake Disorders, Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indonesian-language application-based auditory guided imagery therapyOther

    This study used a mobile application developed by researchers using Indonesian language to deliver an auditory guided imagery therapy

  • PsychoeducationOther

    Psychoeducation consists of sleep hygiene and relaxation therapy (breathing exercise, progressive muscle relaxation, and guided imagery)

Study groups in NCT07141940
Study groupRoleWhat they receive
Intervention GroupExperimentalThe participants receive psychoeducation at the enrollment. Then, they were asked to use the Indonesian-language application-based auditory guided imagery therapy 3 times a week for 4 weeks.
Receives: Other: Indonesian-language application-based auditory guided imagery therapy
Control GroupActive comparatorThe participants receive only psychoeducation at the enrollment.
Receives: Other: Psychoeducation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insomnia Severity Index

    Measured: 4 weeks

  2. Fasting Plasma Glucose

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2025
  2. Study start6 May 2025
  3. Primary completion19 Aug 2025
  4. Study completion19 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07141940
Sponsor's protocol ID
RSCM_IPD_PPM_2025.01
Status last verified
Mar 2025
First submitted
19 Aug 2025
Last updated
26 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Indonesian-language application-based auditory guided imagery therapy and Psychoeducation in people with Diabetes (Insulin-requiring, Type 1 or Type 2) and Insomnia Type; Sleep Disorder, run by Dr Cipto Mangunkusumo General Hospital at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insomnia Severity Index (time frame: 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in